Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male and female patients of age 18- 65 years with American Society of Anaesthesiologists- Physical Status Grade 1 and 2 posted with indication for nasotracheal intubation i.e. undergoing surgery involving oral cavity, mandible, maxilla, thyroid, neck, difficult airway with decreased mouth opening, cervical spine, etc
Exclusion criteria
Exclusion criteria: 1) Patients who shall not give consent 2) Patients with nasal pathology (septal deviation, turbinate hypertrophy, nasal polyp and trauma) 3) Patients with history of common cold during prior 2 weeks or treatment with nasal decongestants, anti-histamines, NSAIDS 4) Patients with coagulopathy and on anticoagulants 5) Patients with drug allergy, chronic pain syndrome, on analgesic medication 6) Pregnant patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of incidence and severity of epistaxis during fiberoptic-guided nasotracheal intubationTimepoint: At the time of intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Hemodynamic changes following administration of topical vasoconstrictor agents 2) Patient discomfort, pain and satisfaction scoring 24 hours after extubation Timepoint: 1)Hemodynamic changes at time 0 minute, 1 minute, 10 minutes following administration of topical vasoconstrictor agents 2) Patient discomfort, pain and satisfaction scoring 24 hours after extubation | — |
Countries
India
Contacts
Sanjay Gandhi Postgraduate Institute of Medical Sciences